Anika Therapeutics | ANIK - Stock


Anika Therapeutics reported $28.56M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Agios Pharmaceuticals USD 35.75M 665K Jun/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 142.38M 9.48M Jun/2026
Integra LifeSciences USD 492M 3.03M Jun/2026
Intrexon USD 287K 68K Dec/2022
J&J USD 15.14B 561M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Merit Medical Systems USD 374.11M 21.73M Jun/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Sanofi EUR 24.12B 620M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Veracyte USD 22.66M 1.24M Jun/2026
Zimmer Biomet Holdings USD 2.27B 23.5M Jun/2026